Your browser doesn't support javascript.
loading
The effects of iodine 131 treatment on chromosomal and oxidative DNA damage in papillary thyroid carcinoma.
Bitgen, Nazmiye; Bayram, Fahri; Hamurcu, Zuhal; Baskol, Gulden; Ozturk, Figen; Abdulrezzak, Ummuhan; Donmez-Altuntas, Hamiyet.
Afiliación
  • Bitgen N; Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Bayram F; Department of Endocrinology and Metabolism, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Hamurcu Z; Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Baskol G; Department of Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Ozturk F; Department of Pathology, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Abdulrezzak U; Department of Nuclear Medicine, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
  • Donmez-Altuntas H; Department of Medical Biology, Faculty of Medicine, Erciyes University, Kayseri, Turkey. Electronic address: donmezh@erciyes.edu.tr.
Article en En | MEDLINE | ID: mdl-39147446
ABSTRACT
Papillary thyroid carcinoma (PTC) is a common endocrine cancer with a good prognosis. Radioactive iodine is thought to be useful for individuals who have had a total or almost total thyroidectomy, but its effects are still controversial. The effects of radioactive iodine-131 (I-131) treatment on oxidative and chromosomal damage in PTC patients were examined in this study, which was carried out with 16 patients newly diagnosed with PTC and 20 healthy control subjects with similar age and gender. Blood samples were taken from patients with PTC at five sampling times (before total thyroidectomy, after total thyroidectomy, and seven days, six months, and one year after treatment) and from control subjects. The cytokinesis block micronucleus cytome (CBMN-cyt) assay parameters in peripheral blood lymphocytes of patients with PTC and controls were evaluated and plasma 8-hydroxydeoxyguanosine (8-OHdG) levels were measured. Furthermore, genome instability and oxidative DNA damage in peripheral blood lymphocytes and plasma of patients with PTC were evaluated before total thyroidectomy (n=16), after total thyroidectomy (before I-131 treatment) (n=16), seven days (n=10), six months (n=5), and one year after treatment (n=5). The numbers of CBMN-cyt assay parameters (micronucleus; MN and nucleoplasmic bridges; NPB) and 8-OHdG levels in patients with PTC were determined to be significantly higher than in those of the control subjects and these values significantly decreased after total thyroidectomy (before I-131 treatment). While the number of MN, apoptotic, and necrotic cells increased after I-131 treatment, it significantly decreased after six months and one year after treatment. The results achieved in this study suggest that I-131 treatment may pose a threat to cells and that radioactive iodine therapy should be avoided (if possible) for patients with PTC after total thyroidectomy.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroidectomía / Daño del ADN / Neoplasias de la Tiroides / Estrés Oxidativo / Cáncer Papilar Tiroideo / Radioisótopos de Yodo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mutat Res Genet Toxicol Environ Mutagen Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tiroidectomía / Daño del ADN / Neoplasias de la Tiroides / Estrés Oxidativo / Cáncer Papilar Tiroideo / Radioisótopos de Yodo Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Mutat Res Genet Toxicol Environ Mutagen Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos